Development of Displacement Binding and GTPγS Scintillation Proximity Assays for the Identification of Antagonists of the μ-Opioid Receptor

Assay and Drug Development Technologies

Volumn 1, Issue 5, 2003, Pages 627-636

  Rodgers, George ^a   Hubert, Cassandra ^a   Mckinzie, Jamie ^a   Suter, Todd ^a   Statnick, Michael ^a   Emmerson, Paul ^a   Stancato, Louis ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; NARCOTIC ANTAGONIST;

ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; CHO CELL; CRICETULUS; DRUG ANTAGONISM; EVALUATION; HAMSTER; METHODOLOGY; PROTEIN BINDING; RADIOASSAY; REPRODUCIBILITY; SCINTILLATION COUNTING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); NARCOTIC ANTAGONISTS; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; REPRODUCIBILITY OF RESULTS; SCINTILLATION COUNTING; SENSITIVITY AND SPECIFICITY;

EID: 2542486572     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/154065803770380986     Document Type: Article

References (27)

1. Reisine T, Pasternak G: Opioid analgesics and antagonists. In: Goodman and Gilman's The Pharmacological Basis of Experimental Therapeutics, 9e, Hutchinson L, Shields T (eds), pp. 521–555. McGraw-Hill, New York, 1996.
2. Vaccarino AL, Kastin AJ: Endogenous opiates: 1999. Peptides 2000;21:1975–2034.
3. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL: Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 2000;25:195–200.
4. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M: International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996;48:567–592.
5. Sharma SK, Nirenberg M, Klee WA: Morphine receptors as regulators of adenylyl cyclase. Proc Natl Acad Sci 1975;72:590–594.
6. Williams JT, Christie MJ, Manzoni O: Cellular and synaptic alterations mediating opioid dependence. Physiol Rev 2001;81:299–343.
7. Pert C, Solomon S: Opiate receptor: demonstration in nervous tissue. Science 1973;179:1011–1014.
8. Pert C, Solomon S: Opiate receptor binding of agonist and antagonist affected differentially by sodium. Mol Pharmacol 1974;10:868–879.
9. Clark MJ, Carter BD, Medzihradsky F: Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig. Eur J Pharmacol 1988; 1148:343–351.
10. Chang KJ, Rigdon GC, Howard JL, McNutt RW: A novel and selective nonpeptide delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 1993;267:852–857.
11. Goldstein A, Naidu A: Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 1989;36:265–272.
12. Emmerson PJ, Liu MR, Woods JH, Medizihradsky F: Binding affinity and selectivity of opioids at mu, delta, and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 1994;271:1630–1637.
13. Sharma SK, Nirenberg M, Klee WA: Morphine receptors as regulators of adenylyl cyclase. Proc Natl Acad Sci USA 1975;72:590–594.
14. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 1995;47:848–854.
15. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F: Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther 1996;278:1121–1127.
16. Stryer L: Biochemistry: Membrane Structure and Dynamics, p. 271. W.H. Freeman and Company, New York, NY, 1995.
17. Lasie D: Liposomes in Gene Delivery. CRC Press LCC, Boca Raton, FL, 1997.
18. Huang F, Buchwald P, Browne CE, Farag HH, Wu WM, Ji F, Hochhaus G, Bodor N: Receptor binding studies of soft anticholinergic agents. AAPS PharmSci 2001;3:E30.
19. Janssen MJ, Stegman M, Ensing K, de Zeeuw R: Solubilized benzodiazepine receptors for use in receptor assays. J Pharm Biomed Anal 1996;14:989–996.
20. Janssen MJ, Ensing K, de Zeeuw R: Stability of solubilized benzodiazapine receptors. Prep Biochem Biotechnol 1997;27:209–217.
21. Baier S, McClements DJ: Impact of preferential interactions on thermal stability and gelatin of bovine serum albumin in aqueous sucrose solutions. J Agric Food Chem 2001;49:2600–2608.
22. Motulsky H: Analyzing saturation binding with ligand depletion. In: Analyzing Data with GraphPad Prism, pp. 164–167. GraphPad Software Inc., San Diego, CA, 1999.
23. + regulation of agonist binding but does not alter receptor-G-protein association. Mol Pharmacol 1993;44:380–384.
24. Kosterlitz H, Paterson S, and Robson L: Modulation of binding of opioid receptors by mono- and divalent cations and by cholingeric compounds. J Recep Res 1988;8: 363–373.
25. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67–73.
26. Gilman A: G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1984;56:615–649.
27. Morash SC, Byers DM, Cook HW: Activation of phospholipase D by PKC and GTPgammaS in human neuroblastoma cells overexpressing MARCKS. Biochim Biophys Acta 2000;1487:177–189.